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Abstract
Neurodegenerative disease is a pervasive and insidious disease affecting a large
proportion of the elderly population. Leading to the degeneration of neural tissue throughout the
nervous system, it is a slow and progressive disorder. Because of its nature, it is possible that it
has a connection to circadian rhythms. Circadian rhythms are the endogenous approximately
24-hour rhythms of the body commonly associated with the sleep-wake cycle, but they account
for much more. This review aims to ascertain the relationship between the two by covering
several facets of research pursued in the past five years. Beginning with establishing a basic
understanding of neurodegenerative disease and circadian rhythms before moving on to the
research. Genetic disruption accounts for the subtle yet most influential factor, affecting many
systems later on. Next follows the best researched avenue of sleep followed by the immune
response with neuroinflammation and apoptosis in neuronal tissue. Finally, is a brief overlook of
avenues pursued outside of the brain investigating strong links to the kidneys and the bacteria of
the intestines. With everything combined, it is clear that the relationship here is this
positive-feedback loop of ever-worsening conditions in individuals with neurodegenerative
disease. At the end, brief comments are noted on potential treatments mentioned throughout the
review along with the continued progression and need for new potential avenues of research.
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1 Introduction
Neurodegenerative disease (ND) is a wide-encompassing term for many differing
disorders of the brain. Ranging from neuromotor dysfunction (ataxias) to neurocognitive
dysfunction (dementias). Many known diseases fall into this broad category, including
Alzheimer’s Disease (AD), and Parkinson’s Disease (PD), among others. As known broadly,
these diseases typically develop from the aging brain and many known and unknown risk factors.
Normally, it is seen as wide-ranging cell death in neural tissue in various portions of the central
nervous system (CNS) and the peripheral nervous system (PNS). These diseases are slow,
progressive, and insidious. Individuals afflicted with either of these will be severely neutered
mentally and physically within years of the first major symptoms. Despite what is known about
the symptomatology of the diseases, little is known about their pathology. Many paths are
currently being explored, and one such potential lies within circadian rhythms.
Circadian rhythms (CRs) are rhythmic and endogenous approximately 24-hour
oscillations of the body. Hallmarked by their periodic continuation with or without external
stimuli, these rhythms play many important roles throughout the course of any organism’s day
and life. The most evident to everyone is the sleep-wake cycle, of which is controlled by a
circadian rhythm. While the sleep-wake is arguably one of the most important circadian cycles
moderated, there are other non-circadian rhythms important to life that can influence any
function of the body. Two of these are most active and not always thought of by the public to be
as rhythmic as the sleep-wake cycle: the pulse of the heartbeat and the rhythmic breathing of the
lungs. The latter can be voluntarily regulated by the organism, showing a good example of how a
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rhythm can be influenced, which is why this path of investigation has been so important in trying
to help discern the pathology of NDs.
The effects of how CRs are affected by NDs has been investigated before, yet the
narrative has yet to be well established beyond a few reviews. While the past reviews explore
specific paths such as explicitly genetics or specifically direct effects of neurodegeneration, little
has been done to coalesce the narratives into one cohesive story. It is the hope here, that a story
will be told of how neurodegeneration plays into the degradation of circadian rhythms and how
this collapse leads to exacerbation of ND. A feedback-loop of ever-worsening conditions that
grows unto itself, a collapse of the individual’s brain.

2 Neurodegenerative Disease
As stated, ND is a set of diseases marked by the destruction of neural tissue over a long
period of time. Briefly, the major diseases mentioned throughout the literature, and here too, will
include Alzheimer’s Disease and Parkinson’s Disease. These two are the most researched in the
field of neurodegeneration and feature frequently in research and study.
First, the most well-known is Alzheimer’s Disease, characterized by a typical late-life
onset, usually developing strong symptoms in individuals during their 60s or 70s. In 4-5% of
cases however, these individuals do develop early-onset AD (Mendez, 2012). Neurodegeneration
present in AD shows atrophy of the temporal and parietal lobes, as well as the frontal cortex and
cingulate gyrus, which is responsible for learning, memory, and emotion formation (Wenk,
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2003). However, despite this, AD cannot be confirmed until after the patient’s death, only
inferred beforehand.
Those who were inflicted with AD present with Amyloid-β (Aβ) plaques and
neurofibrillary tangles formed from excess tau protein. The former, Aβ is a normal byproduct of
the amyloid precursor protein (APP) being cleaved by beta and gamma secretase. Normally, this
byproduct is removed from the cerebrospinal fluid and cell bodies during sleep. However, in
individuals with AD this does not appear to be the case as there are large plaques of Aβ mixed
with cellular material densely packed outside of neurons (Ohnishi & Tahano, 2004). And,
beyond the presence of these plaques outside of neurons, there are within neurofibrillary tangles
(NFTs) made of the tau protein, which stabilizes the cytoskeleton of neurons. Tau protein in AD
becomes hyperphosphorylated and collapses, forming these NFTs, destroying the neuron’s
transport system (Hernández & Avila, 2007). While not all-encompassing of the basics for AD, it
is still a poorly understood disease. Though another poorly understood disease is Parkinson’s
Disease
Parkinson’s Disease, much like AD, can only be confirmed after the individual has died.
Because of this, it is difficult to determine the course of the disease within the brain. What is
known is that the major pathological characteristics are Lewy Bodies. Composed of the protein
alpha-synuclein and other minor contributors, are believed to be a clump of severely misfolded
proteins referred to as an aggresome (Tanaka et al., 2004). Alpha-synuclein is responsible for
much of DNA repair and its function is heavily reduced in neurons possessing Lewy Bodies and
because of the lack of DNA repair, neurons would eventually undergo apoptosis. It is unfortunate
that these two diseases are poorly understood and while discussion will not focus on explicitly
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the diseases, it will focus on how one major function plays into their development, circadian
rhythms.

3 Temporal Order of the Body
Circadian rhythms are a complicated feature of the brain and the cells of the body, an
endogenous, rhythmic cycle repeating roughly every 24 hours. Any biological rhythm can be
called circadian if it falls under the following three criteria: 1. The rhythm is an endogenous
period lasting approximately 24 hours persisting through constant conditions such as constant
darkness; 2. The rhythm is entrainable, meaning it can be reset to external stimuli; and 3. The
rhythm compensates for temperature, maintaining consistent periodicity throughout a range of
physiological temperatures. Practically every rhythm of an organism falls under these criteria,
however there would be chaos if not for the suprachiasmatic nucleus (SCN).
Within a small part of the hypothalamus lies the SCN, which is responsible for the
control of nearly half of the circadian rhythms in the body. The so-called “master clock” consists
of approximately 20,000 neurons and exerts much influence over the body of organisms (Gumz,
2016; Weaver, 1998). These neurons within the SCN are special compared to other circadian
clocks present within the body. Other clocks can be entrained by environmental stimuli, and the
SCN is no exception, although it has a special topography. It contains its own “coupling
mechanisms, which allow them to remain synchronized to one another even in constant
darkness” (Welsh et al., 2010), meaning the SCN can act independently of external stimulation,
not in totality however.
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A common term used is the “free-running period” which is the period of a circadian
oscillator in the absence of external stimuli. In a human left in constant light conditions, their
free-running period is about 24 hours and 20 minutes, meaning they will slowly shift out of
alignment. This is due to the SCN not being able to do its job as it controls much of the CRs
present throughout the body by entraining to light. It is a well known statement as mammals are
entrained through photoreception via their eyes, the removal of which destroys the circadian
response to light (Gumz, 2016; Yamazaki et al., 1999). The entrainment of the SCN with the
cycle of night and day is seen on the genetic level with the cyclic manipulation of multiple genes.
Regulation of the SCN’s CR falls down to the molecular level with the oscillation of
transcriptional-translational feedback loops that include BMAL1 and CLOCK. These two genes
heterodimerize to begin modulation of various genes including ones expressing the
cryptochrome (CRY) and period (PER) proteins (Chauhan et al., 2017). Nominally, they promote
the transcription of CRY1/CRY2 and PER1-PER3 which go on to heterodimerize themselves and
inhibit expression of BMAL1 and CLOCK. With a roughly 24-hour oscillation, these four go on
to influence transcription of other clock-controlled genes. It has been estimated that, “... 40-50%
of all protein encoding genes in mice and humans are regulated by the circadian clock …”
(Buijink & Michael, 2021). Seen in the hunger response of the liver to the sleep-wake cycle of
the brain, the SCN establishes a temporal order over the mind and body. Though, this temporal
order can be broken with the development of ND, which is first seen below with breaking the
genetic disposition of the SCN.
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4 Genetic Disruption of the Molecular Clock
The molecular clock of the SCN, responsible for much of the CRs present in the body is a
tenuous cycle as it is dependent on the BMAL1:CLOCK dimer forming and promoting the
cryptochrome and period genes. Neurodegeneration has been observed to disrupt the cyclic
methylation of these parts. In patients with AD, the rhythmic methylation of BMAL1 is altered
with respect to unafflicted individuals (Maiese, 2021). The actual change in rhythmicity is
different in each individual, yet the result is the same; the dimerization of BMAL1 and CLOCK is
disrupted due to the unmatched prevalence of BMAL1 to CLOCK. Considering that the two work
on a cycle akin to a sine wave, if the waveform for BMAL1 is shifted to later, then in the morning
hours there would be an under-expression of genes reliant on the rhythmic oscillation of BMAL1
and CLOCK. In the evening hours, the expression would be nominal, however, as CLOCK would
become the limiting reagent. Of course, the situation would be reversed if the waveform was
shifted to earlier. Effects of this would be wide-ranging, however an evident one that will be
explored later in-depth is sleep. Individuals with AD are not the only ones to suffer from a
shifted rhythmicity of BMAL1. PD patients also exhibit a change.
Patients with PD present with a blunted rhythmicity of BMAL1 within their blood cells
(Hood & Amir, 2017). A study by Delgado-Lara et al. in 2020 found that the expression of
BMAL1 and PER1, in general, was inhibited throughout the body of the 28 human subjects
tested. The relative expression was also measured, of which BMAL1 is normally expressed 30%
less than PER1 (Breen et al., 2014). In the patients measured, they found that the relative
expression was 57% lower than PER1 (Delgado-Lara et al., 2020). Unlike in AD patients where
the cycles are out of phase, here BMAL1 is explicitly dampened. This dampening is present
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across the full day with various effects at day and night. Throughout the day, PD patients exhibit
excessive daytime sleepiness, significantly decreased melatonin circulation in the bodily fluids,
and there is a loss of the circadian dip in blood pressure at night in 71% of patients (Leng et al.,
2019). Part of this may be due to effects of ND seen in the pineal gland as AD also has a role to
play.
AD is also affected in the pineal gland with a chronogenetics study as referenced by
Videnovic et al., who showed that “… the diurnal pattern in the expression of the clock genes
ARNTL, … is lost in the pineal gland of patients with AD” (Videnovic et al., 2014). With the
pineal gland responsible for the secretion of melatonin and many patients of ND known to have a
decreased presence of melatonin, it is reasonable to assume a malfunction within this part of the
brain. CRY1 and PER1 mRNA expression is lost within the pineal gland in patients with ND
(Hood & Amir, 2017). Because of the heterodimerization of these two proteins and their direct
inhibition of the BMAL1:CLOCK heterodimer, it is a logical continuation that there would be a
subsequent decrease in inhibition. Because there is no subsequent damping of the
BMAL1:CLOCK heterodimer, the production of melatonin is inhibited, thus degrading sleep, the
next topic.

5 Sleep of a Decaying Mind
Observations of the elderly population has shown that their length and quality of sleep
goes down as they get older, an adamant symptom of aging. Patients with ND, however,
experience this degradation in sleep quality at a hastened pace. Individuals with ND suffer from
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REM sleep behaviour disorder before classic ND symptoms (Chauhan et al., 2017). Chauhan
goes on to add that 90% of individuals diagnosed with REM sleep behaviour disorder will
develop a ND associated to α-synuclein aggregation, a major component of Lewy Bodies. While
REM sleep behaviour disorder is common to ND patients, there are other factors with sleep at
play.
Mentioned before was melatonin. It is known that the SCN entrains melatonin secretion
(Wu et al., 2019), ultimately, it is the pineal gland that secretes melatonin, and with the pineal
gland losing its expression of BMAL1 (Videnovic et al., 2014) the immediate outlook is poor.
Even early research has shown that there is a marked decrease in the prevalence of CSF
melatonin, and as noted by Uddin et al. melatonin abates the accumulation of Aβ in AD patients
(Uddin et al., 2020). Melatonin has another role beyond abating Aβ accumulation as it also
attenuates the hyperphosphorylation of tau while also limiting oxidative stress in AD (Chen et
al., 2020). There are also effects seen in PD, acting similarly to AD. Melatonin improves
neurotoxicity “... by inhibiting autophagy and α-synuclein aggregation by enhancing the
ubiquitination of α-synuclein in kainic acid-induced mouse model [sic]” (Chen et al., 2020).
Mitochondrial damage seen in some PD patients has also been shown to be reduced in yeast
models. There are other effects of melatonin in ND, however they tend to be less significant,
only showing effects later in life or in rarer ND cases such as those with Batten Disease or
Creutzfeldt-Jakob Disease. Because of the continual decline of sleep quality and length in ND
patients it is not hard to create a causal link between the decline of the CR controlling melatonin
secretion, sleep, and the progression of ND (Chen et al., 2020; Uddin et al., 2020). Melatonin is
also not the only sleep-involved hormone that is affected.
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With much of the research falling into melatonin's court in earlier research, there has been
a recent surge in studies of orexin. Gene-knockout mice of orexin, a peptide responsible for
wakefulness, “… modestly increases sleep time but strongly suppresses the formation of amyloid
plaques in AD model mice” (Musiek, 2016). It is not well known the mechanism by which this
occurs, however orexin is mostly independent of influence from the SCN, and has its own
influence over the sleep-wake cycle. Research has shown that CSF orexin levels are positively
associated with increased Aβ levels and that infusion in mice, “significantly raised interstitial
fluid [unabbreviated] Aβ levels …” and infusion of antagonist, “... almorexant, for 24 h
suppressed ISF Aβ levels in mice” (Wu et al., 2019). Almorexant was intended to be used in
humans; however, research was abandoned. There has been another drug developed as an
antagonist to orexin receptors under the name Lemborexant. Approved by the FDA in 2019, it
was originally used to treat insomnia, however recently, it is under investigation for its potential
in treating irregular sleep-wake rhythm disorder in AD patients. It has shown generally positive
results in ameliorating sleep disruption and is currently in phase II to evaluate long-term
exposure and potential circadian improvements (Scott, 2020). Moving from specific sleep-wake
cycle hormones, comes a short focus on the unfolded protein response.
The unfolded protein response is initiated in the endoplasmic reticulum and is meant to
maintain proteostasis by either removing misfolded proteins or salvaging those that are still
usable. This response is activated often in individuals of ND, as expected. However, the
decreased quality of sleep has shown to alter this response. Researchers have found that a
decrease in sleep leads to an over-activation of the unfolded protein response and that this, “...
over activation of the UPR/maladaptive ER stress response could contribute to
neurodegenerative disease” (Hafycz & Naidoo, 2019). With the sleep cycle being controlled by
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the SCN, the over-activation of the UPR could lead to changes throughout other CRs and may be
another contributor to worsening sleep in ND patients. With α-synuclein being a common
misfolded protein, some research has gone into studying its prevalence in sleep. Transgenic
mouse models for α-synuclein showed changes in the firing rate of the SCN early in the
development of PD along with sleep-wake disturbances separate from SCN misfiring (Videnovic
& Golombek, 2017). All combined so far, sleep presents a poor outlook for ND patients.
However, this field has spawned the most research into potential treatments for ND patients.
Studies have found that poor sleep and sedentary behaviour are linked to negative health
outcomes, one of which is an increased risk for developing “... clinical all-cause dementia and
Alzheimer’s disease …” (Lysen et al., 2020). Thus, there has been a large influx of research on
studying how modulating sleep behaviors among others, can contribute to improving CRs and
the sleep-wake cycle itself while reducing the pathogenesis of ND. Much of the research has
shown improved results, but as noted by Ferini-Strambi et al. well designed control experiments
are a necessity with how unreliable they can be (Ferini-Strambi et al., 2020). Thus, the following
had more strict requirements to enter this review. One of these experiments included studying the
effects of tailored light intervention. This is a method by which individuals are entrained
forcefully by tailoring the day/night cycle to maximize the effects on the circadian system. One
study found that by performing this method, there was a significant improvement in self-reported
sleep quality and objective sleep efficiency (Figueiro et al., 2019). While not immediately
indicative of much, as shown before, decreased sleep quality does lead to exacerbated
progression of symptomatology in individuals with ND. Thus controlling one major CR, the
sleep-wake cycle, will have a positive impact on pathogenesis.
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Another promising study investigated the potential of intermittent fasting and
time-restricted feeding. This study was conducted by Jamshed et al. in 2019. The methodology
here was to restrict the eating patterns of individuals to an early schedule, from 8 A.M. to 2 P.M.
Results measured in this experiment included glucose monitoring of course, but also expression
of those genes related to glucose metabolism and the circadian system. One of the results found
that cortisol levels, another important hormone in wakefulness, had slightly increased levels in
the morning hours and slightly decreased in the evening hours. And of the circadian genes, the
treatment “significantly increased the expression of the circadian clock genes BMAL1, CRY1,
CRY2, and RORA in the morning” (Jamshed et al., 2019). The evening hours also showed a
decreased expression of PER1 and another increase in CRY1, CRY2, and RORA along with an
increase to REV-ERBA. As seen earlier, with the loss of expression of BMAL1 and CRY1 in the
pineal gland of ND patients, having an overall increased expression of the two throughout the
body is promising. While not immediately indicative of increased sleep length, it is promising.
Though sleep is a well researched field, the following is not as well understood and likely has a
stronger influence over pathogenesis.

6 Neuroinflammation and the Interstitial Space
Neuroinflammation is another complex facet of the CNS with many key influences in ND
and CRs. Microglia is one of the cell types that spearheads the neuroinflammatory response by
monitoring the situation and shaping neural circuitry. They can be activated by numerous
methods, some of which include amyloid-β, α-synuclein, proinflammatory cytokines, among
others (Homolak et al., 2018). Astrocytes also get involved in the response by downregulating
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expression of aquaporin-4, decreasing the rate of water flow between cells and the interstitial
fluid (Homolak et al., 2018; Valori et al., 2021). Astrocytes also regulate neuronal transmission
(Wang & Li, 2021). CRs play into this by modulating the active and inactive phases of the
neuroinflammatory response.
In the active phase, “... leukocyte recruitment is increased, along with circulating levels
of epinephrine, norepinephrine and TNF-α …” and in the resting phase, “... characterized by
lower expression of endothelial adhesion molecules and an enhanced pooling of immune cells
from the bone marrow to the blood” (Homolak et al., 2018). This is the general circadian
response to inflammation, but when applied specifically to neuroinflammation; a review by
Musiek and Holtzman from 2016 references the influence of CRs on the neuroimmune system
and how action employed by it can be changed by NDs. They describe how,
“Neuroinflammation, often propagated by activation of astrocytes and microglia, is a major
contributor to neuroinflammation,” followed by “Astrocytes exhibit robust circadian clock
function … Microglia also have functional circadian clocks …” describing succinctly the effects
of the immune response and a circadian influence.
Astrocytes and microglia, “Upon injury and disease of the CNS, … become ‘reactive’ …
is characterized by the generation of an inflammatory environment into the nervous tissue”
(Valori et al., 2021). This activation does not need to be exogenous in origin either, as
endogenous disease and injury also leads to the activation of astrocytes, microglia and the CR
associated with them. A study performed by Pillai et al. in 2021 showed the circadian response to
neuroinflammation in AD patients as seen before in other experiments. However, they
experimented to see how CRs are disrupted due to the immune response. Pillai et al. found that
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there are, “circadian rhythm irregularities accompanied by 1) altered humoral immune responses
in both the CSF and the plasma, i.e., circadian disruption was associated with altered immune
profiles and 2) increased CSF neurodegeneration biomarkers (p-tau and t-tau)” (2021).
Emanating the proposition that there is a feedback loop present between the immune system and
CR in relation to ND’s disruption of the nervous system. Expanding upon the second point, tau
seems to have a rhythmic presence in interstitial brain fluid.
A study by Holth et al. examined in mice the degree to how much tau protein is prevalent
in the brain’s interstitial fluid. They state the following, “... ISF tau is regulated by the
sleep-wake cycle and that both ISF tau in mice and CSF tau in humans are strongly increased in
sleep deprivation… Thus, changes in the sleep-wake cycle can result in rapid changes in ISF and
CSF tau” (2019). With tau being one of the major components to AD gaining more prominence
in sleep-deprived individuals and seeing from before how sleep deprivation is endemic to ND, it
presents another spiraling feedback loop. Normally, the immune system would get involved, but
again, as seen earlier in this section, its effectiveness is hampered due to the effects of ND.
Ultimately, it may come down to autophagy and apoptosis as another means to hamper
progression.

7 Autophagy and Apoptosis
Autophagy, the natural degradation within cells, recycling the components and breaking
down non-functioning or otherwise useless organelles. Extensive research has gone into
observing the relationship between autophagy and ND because this is one of the major failure
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points seen in the nervous system. Autophagy is meant to destroy many of the misfolded proteins
and byproducts that are seen in ND like Aβ and tau. Circadian dysfunction during the process of
aging and ND has been shown to induce autophagy (Luo et al., 2020; Maiese, 2017). Certain
neuropeptides in Drosophila models have also been shown to induce apoptosis, the rapid,
programmed death of a cell. These peptides include pigment dispersing factors and insulin-like
peptides. The relationship to ND, CRs, and apoptosis is summarized succinctly as, “These
signaling molecules convey important network connectivity and signaling information for
normal circadian function …” as they are necessary in modulating the morning and evening
binding sites for circadian function, and “... convey signals that lead to apoptosis, enhanced
neurodegeneration and cognitive decline in flies carrying circadian mutations or in a senescent
state” (He et al., 2017). This shows a strong connection in Drosophila models between CRs and
ND, although the connection in humans is less clear.
Humans are much more complicated than simple house flies, so there is less available
research as to the connection of autophagy and apoptosis with CRs and ND. MicroRNA is a
small avenue that has been explored, and it has only established a tenuous relationship. A
specific miRNA sequence has been noted to be involved in autophagy, “Although the actual
targets of miR-30c have not been identified, a computational algorithm revealed many target
genes that are involved in neuronal autophagy, mitophagy and the regulation of dopaminergic
cell death” (Kinoshita et al., 2020). It is believed that this miRNA targets and downregulates
PER expression. The same study also found that miR-19b expression, involved in protecting
against neuronal apoptosis, is lowered in PD patients. The miR-19b is believed to be a regulator
of CLOCK and RORA, another clock gene responsible for stabilizing the oscillation of the
molecular clock. This lowered expression has been observed in patients diagnosed with REM
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sleep behaviour disorder years prior to a diagnosis of PD (Kinoshita et al., 2020). Though again,
this shows a correlative relationship, and it is uncertain if either of these miRNAs are fully
responsible for the effects observed. It is with this too, that research begins to move outside of
just the brain, as there have been many avenues outside of the CNS that have been investigated.

8 Beyond the Brain
There are other factors that have their role in the development of ND and the existence of
CRs. As stated before, CRs are present throughout the body and the majority are controlled by
the SCN. Some major organs have these rhythms controlled by the SCN and are thus also
affected by neurodegeneration. Organelles within cells are also affected by neurodegeneration,
especially within neurons outside the CNS. A heavy focus on research has existed looking into
the parts of the body affected by ND and CRs that are not a direct part of the CNS. This ranges
from the urinary system to the intestinal tract and down to the mitochondria of the cells. Starting
off are the larger organs, the kidneys and the intestines.
Kidneys are vital to the functioning of any organism possessing them. They possess an
interesting interaction with the CNS and the response to them. It is well known that kidney
dysfunction can lead to toxic uremia of the blood which can have adverse effects on the nervous
system. In a review, Tanaka and Okusa in 2019 cover some of the effects that chronic kidney
disease and renal failure have on the nervous system. In summary, the existence of either kidney
disease or renal failure increases the incidence of both stroke and dementias. Either of these can
exacerbate already present conditions of ND. Also mentioned is the direct influence the pituitary
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gland has over the actions of the kidneys. Considering the pituitary gland is activated by the
hypothalamus and to an extent, the SCN, it is noted in the review that there is a potential link
between potential degradation of the hypothalamus and continued proper functions of the
kidneys (Tanaka, 2019). Moving from the kidneys, another imperative organ, the intestines and
its microbiome.
Intestinal microbiota are almost akin to an organ of their own considering the great power
they may hold over everything to do with digestion and excretion. Because of this, a great deal of
research has been performed on them, including research into their striking diurnal rhythmicity
and the changes in ND. A study by Li et al. in 2021 collected experiments and came to discuss
the role of gut microbiota in CRs and how they change to AD spreading its destruction upon the
nervous system. To summarize, it is not known which happens first, the change of microbiota or
the development of AD, but what is known is that there is a drastic change in the circadian
response of the microbiota, their overall presence and proportions of the various bacteria, and the
effects that are incurred on the individual. Li found that the change in microbiota CRs leads to a
definite increase in sleep loss, increased progression of AD pathology, and the diminishment of
several species of gut microbiota with their own effects. Some of the studies mentioned in Li’s
assessment show that transplantation of certain bacteria in murine models led to the increase of
cognitive function, tryptophan metabolism, and Aβ-degrading enzymes. There was also a
decrease in overall Aβ levels and deposition, neuroinflammation and related cytokines, cognitive
impairment, and decreased impairment of CRs (Li et al., 2021). This comprehensive study
succinctly describes how important CRs are to the gut microbiome and how this microcosm
drastically changes its host’s response to ND. With this striking research in the small world of the
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intestinal tract, more research has progressed on another small organ found inside cells, the
mitochondria.
Mitochondria are often termed “the powerhouse of the cell,” and while this is not
inaccurate it is not descriptive of their entire role. In ND, mitochondria have roles separate from
generating vast quantities of ATP. Such roles include the storage and dissemination of calcium,
apoptosis, and, in neurons, contributing to cell quality by reporting to microglia on a rhythmic
basis (Cserép et al., 2020). A review by Perez Ortiz and Swerdlow explained that in
mitochondria, “Decreased regional blood flow and oxygen utilization in AD brain provide more
direct evidence implicating impaired mitochondrial respiration in disease” (2019). Continuing
this, they add that there are specific proteins in the electron transport chain that are dysfunctional
or lost, which seems to be the cause here. Considering the importance mitochondria have in the
brain, decreasing the ability of mitochondria to do anything aligns with the general issue of
cognitive decline in ND. Also, the decline of mitochondrial activity would contribute to the issue
presented earlier of neuroinflammation. Because the mitochondria are unable to signal microglia
that something is wrong, it is up to the immune system to determine if a cell needs to undergo
apoptosis. Although as seen before, apoptosis is not always reliable in individuals with ND.

Conclusions
Influence over the body is something that requires precision if it is to be rhythmic and
consistent. Evidently seen in the generation of circadian rhythms, it is clear that they are a
sensitive, ever present system in organisms. It is clear that with its innate sensitivity, that even a
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simple disease or alteration could have drastic effects on CRs, especially the SCN. Though,
simple disease is not descriptive of Neurodegenerative Disease. These diseases are pervasive
throughout the brains of individuals, wreaking havoc as they progress leading to many changes
of not just the mind but the delicate system setup by the SCN. Disturbances in CRs can be seen
years prior to any other clinical symptom of ND (Duncan et al., 2021). Though, it is only in
recent years that study of this avenue has occurred, and due to the complexity of both CRs and
NDs research is slow (Videnovic & Willis, 2016). Research has shown that there are many links
between CRs and ND, from the well-understood sleep disturbances to lesser understood
interactions with the intestines and kidneys.
Molecular disturbances are evident in the SCN with a reduction in the expression of
BMAL1, crucial to the stability of the rhythmicity of CRs in the brain and throughout the body.
Other genes have only recently been attributed to CRs in ND such as those in the rapamycin and
Wnt pathways (Maiese, 2021). The loss of expression in these genes leads to many issues further
along and can be partly attributed to most other interactions seen (Carter et al., 2021) such as in
sleep with the obvious sleep-wake cycle disturbance. Melatonin and orexin are the two involved
hormones hit most hard. Surprisingly, little research has examined glucocorticoids such as
cortisol, which are not explicitly involved in sleep but do play a role due to their influence on
metabolism (Carter et al., 2021, Duncan et al., 2021). Yet, there are more factors concerning
sleep as AD on its own has different sleep disturbances than PD (Phan & Malkani, 2018).
Regarding sleep, while it has been the most thoroughly researched avenue, the “Mechanisms
underlying the connection between circadian/sleep dysregulation and neurodegeneration remain
unclear …” (Mattis & Sehgal, 2016). This connection is still not clear, but the effects are all too
obvious. Though, from here research progresses to less understood mechanisms.
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Neuroinflammation has been noted to occur in ND patients with disturbances to the
mechanisms of astrocytes and microglia. This appreciation for the relationship between ND and
immunology has led to a recent avenue into circadian control of the immune system.
Astrogliosis, the increased production of astrocytes, is one point of contention that has only
recently been found to be increased in ND (Carter et al., 2021), and because they are the most
influential factors in neuroinflammation, they have had much scrutiny in their effects. Though,
they can’t do everything and may leave the immune response up to autophagy and apoptosis. Of
which has been noted to completely fail in most cases or exacerbate neuroinflammation (Phan &
Malkani, 2018). Beyond the brain, the kidneys and intestines provide additional points of failure.
The kidneys can fail due to the alterations of the SCN and thus might induce kidney disease,
hurting the brain even more. Intestinal microbiota have been shown to drastically alter the course
of ND pathogenesis yet are tied to the host’s CRs in rodent models. All combined, it is a poor
outlook.
This vicious cycle between ND and CRs is horrific to outsiders, researchers, and the
afflicted. Created from this is a positive-feedback loop between the two. As ND progresses, it
begins to alter the master clock and other CRs. These alterations then produce effects that can
then lead to further pathogenesis of ND. While it may seem obvious, it has only been in the past
year that these conclusions could begin to be more than correlational (Sharma et al, 2021).
Causation is something that is being confirmed in some cases and the hope is that soon, a direct
and causational connection can be established. Hence, why there needs to be further research
between the two. Therapies are also something that can be looked into now as well.
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Genomic engineering has been a field of therapy targeted in animal models for the past
decade and has shown progress, but the applicability to humans is tenuous (Raslan & Kee, 2013).
Though recently, methods to target nuclear receptors, transcription factors regulating expression
of various genes, have begun in animals. This line of therapy is more viable in humans as it does
not require as much genomic engineering as in other cases (Moutinho et al., 2019). Though, this
line can be considered beyond invasive. Thus, less invasive therapies have been theorized and
tested. Some seen before include light therapy and intermittent fasting which have been shown to
be effective. Other methods include pharmacologically based methods. Lemborexant was one
mentioned, however other pharmacological agents such as histamine drugs and glucocorticoids
have been suggested as effective means to pursue (Colwell, 2021). Although, more research
needs to be done on the efficacy of such means.
Ultimately, the vicious relationship between ND and CRs comes down to the
positive-feedback loop. Understanding what other factors play into and come from this loop are
necessary to treat ND. As noted by Videnovic, “... intervening with circadian function provides a
novel research avenue down which new strategies for improving symptomatic treatment and
slowing of the progressive degenerative process can be approached …” (2016). This statement
was made six years ago, and holds truer more now than ever. This relationship is something that
can lead to targeted therapies of which some have already shown to improve individual
symptoms, but have yet to show any creedence towards improving pathogenesis. Therefore,
research and therapies must be further developed if humanity is ever to rid itself of ND.
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